In the News
05/09/23
Opin.AI Breaks Down Barriers in Clinical Trial Participation
17/01/23
2023 Prepped and Primed: Opyl (ASX:OPL) with CEO, Michelle Gallaher
07/12/22
Year in Review: Opyl (ASX:OPL) with CEO, Michelle Gallaher
07/11/22
Big data could cure cancer
21/10/22
Opyl’s TrialKey achieves major milestone with potential to improve clinical trial success rates
30/09/22